US3635985A - 3-phenyl-4-acyloxycarbostyrils - Google Patents
3-phenyl-4-acyloxycarbostyrils Download PDFInfo
- Publication number
- US3635985A US3635985A US6316A US3635985DA US3635985A US 3635985 A US3635985 A US 3635985A US 6316 A US6316 A US 6316A US 3635985D A US3635985D A US 3635985DA US 3635985 A US3635985 A US 3635985A
- Authority
- US
- United States
- Prior art keywords
- phenyl
- acyloxycarbostyrils
- acetoxycarbostyril
- sec
- ethoxycarbonyloxycarbostyril
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
Definitions
- R is methyl or ethoxy prepared by treating 3- phenyl-4-hydrocarbostyril with an acylating agent, which is useful as a minor tranquilizer with less side eifect and low toxicity.
- the present invention relates to 3-phenyl-4-acyloxycarbostyrils, and their production and use.
- the said 3-phenyl-4-acyloxycarbostyrils are representable by the formula:
- R is methyl or ethoxy and include specifically 3- phenyl-4-acetoxycarbostyril and 3 phenyl-4-ethoxycarbonyloxycarbostyril.
- 3-phenyl-4-acyloxycarbostyrils [I] exert a taming effect in fighting mice.
- mice of dd strain weighing 18 to 20 g. each were used and divided into 5 groups each consisting of a pair. Two mice were put on an electrical stimulator and a 200 ml. beaker was placed upside down over the mice. Electric stimulation was given at the intervals of 7 sec. (540 v., 3 ma.). The time until two mice began to fight was measured with a timer at various times after administration of the test compound and calculated in terms of the score of 1 to 9 respectively for 0 to 5 sec., 6 to 10 sec., 11 to 15 sec., 16 to 20 sec., 21 to 25 sec., 26 to 30 sec., 31 to 35 sec., 36 to 40 sec. and more than 40 sec. The dosage showing an average mark of 5 was taken as ED Results ED (mg/kg,
- Test compound per os) 3phenyl-4-acetoxycarbostyril 11.5 3-phenyl-4-ethoxycarbonyloxycarbostyril 10.5 3-phenyl-4-hydroxycarbostyril 100 3-phenyl-4-propionyloxycarbostyril 96.0 3-phenyl-4-phenacetyloxycarbostyril 100 3-phenyl-4-benzoyloxycarbostyril 100 3-phenyl-4-propoxycarbonyloxycarbostyril 96.0 3-phenyl-4-phenyloxycarbonyloxycarbostyril 100 1-ethyl-3-phenyl-4-acetoxycarbostyril 100 1-ethyl-3-phenyl-4-ethoxycarbonyloxycarbostyril 100 1-methyl-3-phenyl-4-hydroxycarbostyril 100 1-ethyl-3-phenyl-4-hydroxycarbostyril 100 chlordiazepoxide 18.0
- the 3-phenyl-4- acyloxycarbostyrils [I] are less effective in muscle relaxation, which is considered as an unfavorable side action for the use of tanquilizers.
- the ED values of 3-phenyl-4-acetoxycarbostyril and 3-phenyl-4-ethoxycarbonyloxycarbostyril are respectively 113.0 and 117.0 mg./kg. whereas the ED value of chlordiazepoxide is 45.3 mg./kg.
- the toxicity of the 3-phenyl- 4-acyloxycarbostyrils [I] is extremely low.
- the LD values of 3-phenyl-4-acetoxycarbostyril and 3-phenyl-4-ethoxycarbonyloxycarbostyril are both more than 3,000 mg./kg.
- the LD value of chlordiazepoxide is 1,325 mg./kg.
- 3-phenyl-4-acyloxycarbostyrils [I] of the present invention are useful as minor tranquilizers with less side effect and low toxicity.
- a clinical dosage of the 3-phenyl-4-acyloxycarbostyrils [I] depends on disease syndrome, body weight, age and administration mode, but it is generally in the range of 0.05 to 500 mg./day, preferably of 0.5 to 200 mg./day. They can be used in a unit dosage form as tablets or capsules for oral administration or optionally in combination with suitable adjuvants such as calcium carbonate, starch, lactose, talc, magnesium stearate, carboxymethyl cellulose and gum acacia. Further, they can be formulated into aqueous alcohol, glycol, oil solutions or oil-water emulsions for oral administration in the same manner as conventional medical substances are formulated.
- the 3-phenyllacyloxycarbostyril [I] is prepared by subjecting 3-phenyl- 4-hydroxycarbostyril of the formula:
- the acylation may be accomplished in one or two steps.
- the 3-phenyl-4-hydroxycarbostyril [II] or its monoalkali metal salt is treated with the reactive derivative of acetic acid or of carbonic acid ethyl ester in the presence or absence of a basic catalyst such as organic tertiary amine (e.g. pyridine, triethylamine, dimethylaniline) at a temperature from to 200 C., preferably from to 120 C.
- a basic catalyst such as organic tertiary amine (e.g. pyridine, triethylamine, dimethylaniline)
- the reactive derivative may be acid halide, acid anhydride, nitrophenyl ester, thiocyanate, dithiocarbamate, trithiophosphonate or the like.
- an inert organic solvent e.g. benzene, toluene, dioxane, carbon tetrachloride.
- the 3-phenyl-4-hydroxycarbostyril [II] or its monoalkali metal salt e.g. sodium salt, potassium salt
- phosgene or nitro-substituted phenoxycarbonyl chloride e.g. p-nitrophenoxycarbonyl chloride
- an inert organic solvent e.g. dichloromethane, chloroform, dioxane, tetrahydrofuran
- the above materials are mixed together, granulated and tableted in accordance with a conventional method to give 2,000 tablets, each weighing 50 mg.
- R is methyl or ethoxy
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
A 3-PHENYL-4-ACYLOXYCARBOSTYRIL OF THE FORMULA:
2-(O=),3-PHENYL,4-(R-COO-)-1,2-DIHYDROQUINOLINE
WHEREIN R IS METHYL OR ETHOXY PREPARED BY TREATING 3PHENYL-4-HYDROCARBOXTYRIL WITH AN ACYLATING AGENT, WHICH IS USEFUL AS A MINOR TRAQUILIZER WITH LESS SIDE EFFECT AND LOW TOXICITY.
2-(O=),3-PHENYL,4-(R-COO-)-1,2-DIHYDROQUINOLINE
WHEREIN R IS METHYL OR ETHOXY PREPARED BY TREATING 3PHENYL-4-HYDROCARBOXTYRIL WITH AN ACYLATING AGENT, WHICH IS USEFUL AS A MINOR TRAQUILIZER WITH LESS SIDE EFFECT AND LOW TOXICITY.
Description
United States Patent 3,635,985 S-PHENYL-4-ACYLOXYCARBOSTYRILS Haruki Nishimura, Osaka-fu, and Yasutaka Nagai, Kyotofu, Japan, assiguors to Dainippon Pharmaceutical Co.,
Ltd., Higashi-ku, Osaka-shi, Osaka-fu, Japan N0 Drawing. Filed Jan. 27, 1970, Ser. No. 6,316 Claims priority, application Japan, Feb. 1, 1969, 44/7,498 Int. Cl. C07d 33/48 U.S. Cl. 260--287 R 3 Claims ABSTRACT OF THE DISCLOSURE A 3phenyl-4-acyloxycarbostyril of the formula:
wherein R is methyl or ethoxy prepared by treating 3- phenyl-4-hydrocarbostyril with an acylating agent, which is useful as a minor tranquilizer with less side eifect and low toxicity.
The present invention relates to 3-phenyl-4-acyloxycarbostyrils, and their production and use.
The said 3-phenyl-4-acyloxycarbostyrils are representable by the formula:
wherein R is methyl or ethoxy and include specifically 3- phenyl-4-acetoxycarbostyril and 3 phenyl-4-ethoxycarbonyloxycarbostyril.
The 3-phenyl-4-acyloxycarbostyrils [I] exert a taming effect in fighting mice. The test results on 3-phenyl-4- acetoxycarbostyril [I:R=CH and 3-phenyl-4-ethoxycarbonyloxycarbostyril [I:R=C H O] as well as some structurally related compounds and a commercially available minor tranquilizer, chlordiazepoxide, are shown below.
Test method Ten male mice of dd strain weighing 18 to 20 g. each were used and divided into 5 groups each consisting of a pair. Two mice were put on an electrical stimulator and a 200 ml. beaker was placed upside down over the mice. Electric stimulation was given at the intervals of 7 sec. (540 v., 3 ma.). The time until two mice began to fight was measured with a timer at various times after administration of the test compound and calculated in terms of the score of 1 to 9 respectively for 0 to 5 sec., 6 to 10 sec., 11 to 15 sec., 16 to 20 sec., 21 to 25 sec., 26 to 30 sec., 31 to 35 sec., 36 to 40 sec. and more than 40 sec. The dosage showing an average mark of 5 was taken as ED Results ED (mg/kg,
Test compound: per os) 3phenyl-4-acetoxycarbostyril 11.5 3-phenyl-4-ethoxycarbonyloxycarbostyril 10.5 3-phenyl-4-hydroxycarbostyril 100 3-phenyl-4-propionyloxycarbostyril 96.0 3-phenyl-4-phenacetyloxycarbostyril 100 3-phenyl-4-benzoyloxycarbostyril 100 3-phenyl-4-propoxycarbonyloxycarbostyril 96.0 3-phenyl-4-phenyloxycarbonyloxycarbostyril 100 1-ethyl-3-phenyl-4-acetoxycarbostyril 100 1-ethyl-3-phenyl-4-ethoxycarbonyloxycarbostyril 100 1-methyl-3-phenyl-4-hydroxycarbostyril 100 1-ethyl-3-phenyl-4-hydroxycarbostyril 100 chlordiazepoxide 18.0
From the above table, it is seen that 3-phenyl-4-acetoxycarbostyril and 3-penyl-4-ethoxycarbonyloxycarbostyril show a higher taming effect than chlordiazepoxide, whereas other structurally related compounds exhibit no material or only slight effect.
In addition, it is advantageous that the 3-phenyl-4- acyloxycarbostyrils [I] are less effective in muscle relaxation, which is considered as an unfavorable side action for the use of tanquilizers. For instance, when orally administered to mice, the ED values of 3-phenyl-4-acetoxycarbostyril and 3-phenyl-4-ethoxycarbonyloxycarbostyril are respectively 113.0 and 117.0 mg./kg. whereas the ED value of chlordiazepoxide is 45.3 mg./kg.
It is also advantageous that the toxicity of the 3-phenyl- 4-acyloxycarbostyrils [I] is extremely low. For instance, when the acute toxicity is determined by administering orally to mice, the LD values of 3-phenyl-4-acetoxycarbostyril and 3-phenyl-4-ethoxycarbonyloxycarbostyril are both more than 3,000 mg./kg., Whereas the LD value of chlordiazepoxide is 1,325 mg./kg.
Thus, the 3-phenyl-4-acyloxycarbostyrils [I] of the present invention are useful as minor tranquilizers with less side effect and low toxicity.
A clinical dosage of the 3-phenyl-4-acyloxycarbostyrils [I] depends on disease syndrome, body weight, age and administration mode, but it is generally in the range of 0.05 to 500 mg./day, preferably of 0.5 to 200 mg./day. They can be used in a unit dosage form as tablets or capsules for oral administration or optionally in combination with suitable adjuvants such as calcium carbonate, starch, lactose, talc, magnesium stearate, carboxymethyl cellulose and gum acacia. Further, they can be formulated into aqueous alcohol, glycol, oil solutions or oil-water emulsions for oral administration in the same manner as conventional medical substances are formulated.
According to the present invention, the 3-phenyllacyloxycarbostyril [I] is prepared by subjecting 3-phenyl- 4-hydroxycarbostyril of the formula:
H [II] to acylation. The acylation may be accomplished in one or two steps.
When carried out in one step, the 3-phenyl-4-hydroxycarbostyril [II] or its monoalkali metal salt (e.g. sodium salt, potassium salt) is treated with the reactive derivative of acetic acid or of carbonic acid ethyl ester in the presence or absence of a basic catalyst such as organic tertiary amine (e.g. pyridine, triethylamine, dimethylaniline) at a temperature from to 200 C., preferably from to 120 C. The reactive derivative may be acid halide, acid anhydride, nitrophenyl ester, thiocyanate, dithiocarbamate, trithiophosphonate or the like. If necessary, there may be employed as the reaction medium an inert organic solvent (e.g. benzene, toluene, dioxane, carbon tetrachloride).
When carried out in two steps, the 3-phenyl-4-hydroxycarbostyril [II] or its monoalkali metal salt (e.g. sodium salt, potassium salt) is first reacted with phosgene or nitro-substituted phenoxycarbonyl chloride (e.g. p-nitrophenoxycarbonyl chloride) in an inert organic solvent (e.g. dichloromethane, chloroform, dioxane, tetrahydrofuran) at a temperature from -10 to C. and the resultant 4-chlorocarbonyloxy compound is then reacted with ethanol in the presence of a basic substance such as alkali metal (e.g. sodium, potassium) or alkoxide of alkali metal (e.g. sodium ethoxide) at a temperature from 10 to 60 C. to obtain the 3-phenyl-4-acyloxycarbostyril [I1 Practical and presently preferred embodiments of th present invention are illustratively shown in the following examples.
EXAMPLE 1 Preparation of 3-phenyl-4-acetoxycarbostyril A mixture of 3-phenyl-4-hydroxycarbostyril (5 g.), acetic anhydride ml.) and pyridine (0.5 ml.) is heated on an oil bath at 120 to 140 C. for 2 hours. The reaction mixture is allowed to stand at room temperature overnight and concentrated under reduced pressure to remove acetic anhydride. The residue is recrystallized from methanol to give 3-phenyl-4-acetoxycarbostyril (4.2 g.) as crystals melting at 252 to 254 C.
EXAMPLE 2 Preparation of 3-phenyl-4-acetoxycarbostyril A mixture of 3-phenyl-4-hydroxycarbostyril (2 g.), pyridine (20 ml.) and acetyl chloride (2.5 g.) is heated on a water bath for 2 hours. The reaction mixture is allowed to stand at room temperature overnight and concentrated under reduced pressure to remove pyridine. The residue is recrystallized from methanol to give 3-phenyl- 4-acetoxycarb0styril (1.9 g.) as crystals melting at 252 to 254 C.
4 EXAMPLE 3 Preparation of 3-phenyl-4-ethoxycarbonyloxycarbostyril EXAMPLE 4 Materials: Grams 3 phenyl 4-ethoxycarbonyloxycarbostyril 5 Lactose Starch 9.5 Microcrystalline cellulose 20 Magnesium stearate 0.5
The above materials are mixed together, granulated and tableted in accordance with a conventional method to give 2,000 tablets, each weighing 50 mg.
What is claimed is:
1. A 3-phenyl-4-acyloxycarbostyril of the formula:
OCOR
wherein R is methyl or ethoxy.
2. 3-phenyl-4-acetoxycarbostyril. 3. 3-phenyl-4-ethoxycarbonyloxyearbostyril.
References Cited UNITED STATES PATENTS 3,542,785 11/1970 Carney 260-289 FOREIGN PATENTS 1,121,411 7/1968 Great Britain 260289 DONALD G. DAUS, Primary Examiner U.S. Cl. X.R.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP749869 | 1969-02-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3635985A true US3635985A (en) | 1972-01-18 |
Family
ID=11667424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US6316A Expired - Lifetime US3635985A (en) | 1969-02-01 | 1970-01-27 | 3-phenyl-4-acyloxycarbostyrils |
Country Status (7)
Country | Link |
---|---|
US (1) | US3635985A (en) |
BE (1) | BE745289A (en) |
CH (1) | CH529760A (en) |
DE (1) | DE2003840A1 (en) |
DK (1) | DK122127B (en) |
FR (1) | FR2030240B1 (en) |
GB (1) | GB1252861A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3994900A (en) * | 1976-01-23 | 1976-11-30 | E. R. Squibb & Sons, Inc. | 6-(Or 8)-[[(substituted amino)alkyl]oxy(or thio)]-3,4-dihydro-4-phenyl-2(1H)-quinolinones |
US4168312A (en) * | 1976-11-12 | 1979-09-18 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Quinolone derivatives |
US7579356B2 (en) | 2005-05-04 | 2009-08-25 | Janssen Pharmaceutica Nv | Thia-tetraazaacenaphthylene kinase inhibitors |
-
1970
- 1970-01-27 US US6316A patent/US3635985A/en not_active Expired - Lifetime
- 1970-01-28 DE DE19702003840 patent/DE2003840A1/en active Granted
- 1970-01-29 GB GB1252861D patent/GB1252861A/en not_active Expired
- 1970-01-30 DK DK44270AA patent/DK122127B/en unknown
- 1970-01-30 BE BE745289D patent/BE745289A/en unknown
- 1970-01-30 FR FR707003333A patent/FR2030240B1/fr not_active Expired
- 1970-02-02 CH CH145370A patent/CH529760A/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3994900A (en) * | 1976-01-23 | 1976-11-30 | E. R. Squibb & Sons, Inc. | 6-(Or 8)-[[(substituted amino)alkyl]oxy(or thio)]-3,4-dihydro-4-phenyl-2(1H)-quinolinones |
US4168312A (en) * | 1976-11-12 | 1979-09-18 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Quinolone derivatives |
US7579356B2 (en) | 2005-05-04 | 2009-08-25 | Janssen Pharmaceutica Nv | Thia-tetraazaacenaphthylene kinase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
DK122127B (en) | 1972-01-24 |
FR2030240A1 (en) | 1970-11-13 |
DE2003840A1 (en) | 1970-07-30 |
CH529760A (en) | 1972-10-31 |
BE745289A (en) | 1970-07-01 |
FR2030240B1 (en) | 1974-06-14 |
GB1252861A (en) | 1971-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1072803A3 (en) | Process for preparing derivatives of phthalazin-4-yl acetic acid or their salts | |
PT91580B (en) | PROCESS FOR THE PREPARATION OF N-SUBSTITUTE NON-SUBSTITUTE NICOTINAMIDE COMPOUNDS | |
JPS60243017A (en) | Antispasmodic composition | |
GB2196962A (en) | Substituted 2-benzyl-mercapto-imidazoles and analogs useful as anti-inflammatory agents | |
US3553258A (en) | Phenylalanine compounds | |
US3635985A (en) | 3-phenyl-4-acyloxycarbostyrils | |
JPS5925794B2 (en) | Heterocyclylcarbonyl derivatives of urea | |
US4590205A (en) | Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes | |
EP0087629A2 (en) | Antiinflammatory and/or analgesic 2,3-Diaryl-5-halo thiophenes | |
US2895877A (en) | Composition and method for relieving spasticity | |
US3177211A (en) | 10-[(aminocarbamyl-1-piperidyl)-loweralkyl]-phenothiazines | |
DE2952594A1 (en) | DISULFID COMPOUNDS | |
US3580910A (en) | P-alkoxy-piperidine-amides | |
JPS5646810A (en) | Blood platelet coagulation inhibitor | |
US3836658A (en) | Tri-substituted imidazoles in the treatment of gout | |
US4774241A (en) | Derivative of benzoquinonylphenyl alkanoic acid amide | |
US4182775A (en) | Benzoic acids and process for their preparation | |
GB1561521A (en) | 3,4 - dihydro - 3 - oxo - 4-carbamoyl - 2h - thieno (2,3 - e) - 1 - 2-thiazine 1,1 - dioxide derivatives | |
JPH0560478B2 (en) | ||
US3622610A (en) | Sulfonate esters of gallic acid derivatives | |
US3886279A (en) | Anti-inflammatory analgesic method of treatment and composition | |
EP0204172B1 (en) | Phenylpyrazine derivatives, processes for preparing them, pharmaceutical composition and use | |
US3497501A (en) | Heterocyclic amino esters of 2-phenylacrylic acid | |
FR2361386A1 (en) | NEW HETEROCYCLIC COMPOUNDS OF THE TETRAHYDRO-4-OXO-4 H-NAPHTO TYPE SUBSTITUTES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM | |
JPH01308227A (en) | Protease inhibitor |